incyte and merus announce global strategic research collaboration to discover and develop bispecific antibodies
conatus announces exclusive worldwide option, collaboration and license agreement covering development and commercialization of emricasan
bristol-myers squibb and calithera biosciences announce clinical collaboration to evaluate opdivo (nivolumab) in combination with cb-839 in clear cell renal cell carcinoma
aurinia announces long-term manufacturing collaboration agreement with lonza for clinical and commercial supply of voclosporin
exelixis and ipsen amend exclusive licensing agreement for the commercialization and development of cabozantinib to include canada
ligand enters commercial license and supply agreements for captisolÂ®-enabled trametinib
: vifor pharma and chemocentryx announce expansion of kidney health alliance to include ccx140 to treat renal diseases
